2 news items
Expert Ratings For Beam Therapeutics
BEAM
23 Apr 24
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $46.2
Expert Outlook: Beam Therapeutics Through The Eyes Of 4 Analysts
BEAM
27 Mar 24
assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Beam Therapeutics compared
- Prev
- 1
- Next